company background image
CRBN logo

Corbion ENXTAM:CRBN Stock Report

Last Price

€17.81

Market Cap

€1.0b

7D

-5.3%

1Y

-7.5%

Updated

13 Apr, 2025

Data

Company Financials +

Corbion N.V.

ENXTAM:CRBN Stock Report

Market Cap: €1.0b

CRBN Stock Overview

Provides lactic acid and lactic acid derivatives, food preservation solutions, functional blends, and algae ingredients in the Netherlands, the United States, Asia, rest of North Americas, and the rest of Europe, the Middle East, and Africa. More details

CRBN fundamental analysis
Snowflake Score
Valuation3/6
Future Growth3/6
Past Performance4/6
Financial Health4/6
Dividends4/6

Rewards

Trading at 62.1% below our estimate of its fair value

Earnings are forecast to grow 25.45% per year

Earnings have grown 2.8% per year over the past 5 years

Risk Analysis

Has a high level of debt

Unstable dividend track record


Corbion N.V. Competitors

Akzo Nobel

ENXTAM:AKZA

€8.4b

DSM-Firmenich

ENXTAM:DSFIR

€22.9b

Aperam

ENXTAM:APAM

€1.8b

Hydratec Industries

ENXTAM:HYDRA

€210.3m

Price History & Performance

Summary of share price highs, lows and changes for Corbion
Historical stock prices
Current Share Price€17.81
52 Week High€26.98
52 Week Low€16.90
Beta1.08
1 Month Change-14.54%
3 Month Change-18.60%
1 Year Change-7.48%
3 Year Change-42.88%
5 Year Change-32.41%
Change since IPO-31.94%

Recent News & Updates

At €17.39, Is Corbion N.V. (AMS:CRBN) Worth Looking At Closely?

Apr 10
At €17.39, Is Corbion N.V. (AMS:CRBN) Worth Looking At Closely?

Corbion's (AMS:CRBN) Earnings May Just Be The Starting Point

Mar 26
Corbion's (AMS:CRBN) Earnings May Just Be The Starting Point
author-image

Expanding Into Natural Antioxidants And Efficiency Improvements Will Drive Future Success

Mar 02 Strategic initiatives and operational optimizations are expected to significantly enhance EBITDA margins and net margins.

Recent updates

At €17.39, Is Corbion N.V. (AMS:CRBN) Worth Looking At Closely?

Apr 10
At €17.39, Is Corbion N.V. (AMS:CRBN) Worth Looking At Closely?

Corbion's (AMS:CRBN) Earnings May Just Be The Starting Point

Mar 26
Corbion's (AMS:CRBN) Earnings May Just Be The Starting Point
author-image

Expanding Into Natural Antioxidants And Efficiency Improvements Will Drive Future Success

Mar 02 Strategic initiatives and operational optimizations are expected to significantly enhance EBITDA margins and net margins.

Here's What To Make Of Corbion's (AMS:CRBN) Decelerating Rates Of Return

Feb 28
Here's What To Make Of Corbion's (AMS:CRBN) Decelerating Rates Of Return

Risks To Shareholder Returns Are Elevated At These Prices For Corbion N.V. (AMS:CRBN)

Dec 18
Risks To Shareholder Returns Are Elevated At These Prices For Corbion N.V. (AMS:CRBN)

Should You Think About Buying Corbion N.V. (AMS:CRBN) Now?

Nov 18
Should You Think About Buying Corbion N.V. (AMS:CRBN) Now?

An Intrinsic Calculation For Corbion N.V. (AMS:CRBN) Suggests It's 26% Undervalued

Oct 31
An Intrinsic Calculation For Corbion N.V. (AMS:CRBN) Suggests It's 26% Undervalued

Corbion (AMS:CRBN) Takes On Some Risk With Its Use Of Debt

Sep 26
Corbion (AMS:CRBN) Takes On Some Risk With Its Use Of Debt

The Price Is Right For Corbion N.V. (AMS:CRBN)

Jul 18
The Price Is Right For Corbion N.V. (AMS:CRBN)

Corbion N.V. (AMS:CRBN) Shares Could Be 25% Below Their Intrinsic Value Estimate

Jun 20
Corbion N.V. (AMS:CRBN) Shares Could Be 25% Below Their Intrinsic Value Estimate

Here's Why Shareholders Should Examine Corbion N.V.'s (AMS:CRBN) CEO Compensation Package More Closely

May 08
Here's Why Shareholders Should Examine Corbion N.V.'s (AMS:CRBN) CEO Compensation Package More Closely

Does Corbion (AMS:CRBN) Have A Healthy Balance Sheet?

Apr 17
Does Corbion (AMS:CRBN) Have A Healthy Balance Sheet?

Investor Optimism Abounds Corbion N.V. (AMS:CRBN) But Growth Is Lacking

Jan 20
Investor Optimism Abounds Corbion N.V. (AMS:CRBN) But Growth Is Lacking

Should You Think About Buying Corbion N.V. (AMS:CRBN) Now?

Dec 18
Should You Think About Buying Corbion N.V. (AMS:CRBN) Now?

Estimating The Fair Value Of Corbion N.V. (AMS:CRBN)

Nov 04
Estimating The Fair Value Of Corbion N.V. (AMS:CRBN)

Corbion (AMS:CRBN) Has A Somewhat Strained Balance Sheet

Sep 13
Corbion (AMS:CRBN) Has A Somewhat Strained Balance Sheet

Returns On Capital Signal Tricky Times Ahead For Corbion (AMS:CRBN)

Aug 04
Returns On Capital Signal Tricky Times Ahead For Corbion (AMS:CRBN)

When Should You Buy Corbion N.V. (AMS:CRBN)?

Jul 14
When Should You Buy Corbion N.V. (AMS:CRBN)?

Corbion N.V. (AMS:CRBN) Shares Could Be 22% Above Their Intrinsic Value Estimate

Jun 04
Corbion N.V. (AMS:CRBN) Shares Could Be 22% Above Their Intrinsic Value Estimate

Here's Why Corbion (AMS:CRBN) Has A Meaningful Debt Burden

Apr 21
Here's Why Corbion (AMS:CRBN) Has A Meaningful Debt Burden

Corbion (AMS:CRBN) Is Paying Out A Dividend Of €0.56

Mar 10
Corbion (AMS:CRBN) Is Paying Out A Dividend Of €0.56

Is Now An Opportune Moment To Examine Corbion N.V. (AMS:CRBN)?

Feb 22
Is Now An Opportune Moment To Examine Corbion N.V. (AMS:CRBN)?

Corbion's (AMS:CRBN) Returns On Capital Not Reflecting Well On The Business

Jan 26
Corbion's (AMS:CRBN) Returns On Capital Not Reflecting Well On The Business

Is Corbion (AMS:CRBN) Using Too Much Debt?

Dec 20
Is Corbion (AMS:CRBN) Using Too Much Debt?

Calculating The Intrinsic Value Of Corbion N.V. (AMS:CRBN)

Nov 24
Calculating The Intrinsic Value Of Corbion N.V. (AMS:CRBN)

Should You Think About Buying Corbion N.V. (AMS:CRBN) Now?

Nov 09
Should You Think About Buying Corbion N.V. (AMS:CRBN) Now?

Corbion (AMS:CRBN) Might Be Having Difficulty Using Its Capital Effectively

Oct 08
Corbion (AMS:CRBN) Might Be Having Difficulty Using Its Capital Effectively

Here's Why Corbion (AMS:CRBN) Has A Meaningful Debt Burden

Sep 19
Here's Why Corbion (AMS:CRBN) Has A Meaningful Debt Burden

A Look At The Intrinsic Value Of Corbion N.V. (AMS:CRBN)

Aug 23
A Look At The Intrinsic Value Of Corbion N.V. (AMS:CRBN)

Is It Time To Consider Buying Corbion N.V. (AMS:CRBN)?

Jul 21
Is It Time To Consider Buying Corbion N.V. (AMS:CRBN)?

Investors Could Be Concerned With Corbion's (AMS:CRBN) Returns On Capital

Jul 06
Investors Could Be Concerned With Corbion's (AMS:CRBN) Returns On Capital

Corbion (AMS:CRBN) Is Due To Pay A Dividend Of €0.56

May 20
Corbion (AMS:CRBN) Is Due To Pay A Dividend Of €0.56

Calculating The Intrinsic Value Of Corbion N.V. (AMS:CRBN)

May 17
Calculating The Intrinsic Value Of Corbion N.V. (AMS:CRBN)

Corbion (AMS:CRBN) Is Due To Pay A Dividend Of €0.56

Apr 28
Corbion (AMS:CRBN) Is Due To Pay A Dividend Of €0.56

Corbion (AMS:CRBN) Has Announced A Dividend Of €0.56

Apr 07
Corbion (AMS:CRBN) Has Announced A Dividend Of €0.56

Corbion's (AMS:CRBN) Returns On Capital Not Reflecting Well On The Business

Mar 26
Corbion's (AMS:CRBN) Returns On Capital Not Reflecting Well On The Business

Corbion (AMS:CRBN) Has Affirmed Its Dividend Of €0.56

Feb 27
Corbion (AMS:CRBN) Has Affirmed Its Dividend Of €0.56

Does Corbion (AMS:CRBN) Have A Healthy Balance Sheet?

Feb 27
Does Corbion (AMS:CRBN) Have A Healthy Balance Sheet?

At €37.02, Is Corbion N.V. (AMS:CRBN) Worth Looking At Closely?

Feb 13
At €37.02, Is Corbion N.V. (AMS:CRBN) Worth Looking At Closely?

A Look At The Intrinsic Value Of Corbion N.V. (AMS:CRBN)

Jan 26
A Look At The Intrinsic Value Of Corbion N.V. (AMS:CRBN)

Here's Why I Think Corbion (AMS:CRBN) Is An Interesting Stock

Dec 22
Here's Why I Think Corbion (AMS:CRBN) Is An Interesting Stock

Corbion's (AMS:CRBN) Returns On Capital Not Reflecting Well On The Business

Dec 10
Corbion's (AMS:CRBN) Returns On Capital Not Reflecting Well On The Business

Shareholder Returns

CRBNNL ChemicalsNL Market
7D-5.3%-4.2%-0.8%
1Y-7.5%-21.9%-15.7%

Return vs Industry: CRBN exceeded the Dutch Chemicals industry which returned -21.9% over the past year.

Return vs Market: CRBN exceeded the Dutch Market which returned -15.7% over the past year.

Price Volatility

Is CRBN's price volatile compared to industry and market?
CRBN volatility
CRBN Average Weekly Movement4.3%
Chemicals Industry Average Movement3.7%
Market Average Movement4.9%
10% most volatile stocks in NL Market8.7%
10% least volatile stocks in NL Market3.3%

Stable Share Price: CRBN has not had significant price volatility in the past 3 months compared to the Dutch market.

Volatility Over Time: CRBN's weekly volatility (4%) has been stable over the past year.

Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

CRBN logo
Corbion
AN
AnalystConsensusTarget
Consensus Narrative from 6 Analysts

Expanding Into Natural Antioxidants And Efficiency Improvements Will Drive Future Success

Key Takeaways Strategic initiatives and operational optimizations are expected to significantly enhance EBITDA margins and net margins. Expanding product adjacencies in food will drive substantial revenue growth while reducing complexity and boosting cash generation.
View narrative
€26.17
FV
31.9% undervalued intrinsic discount
5.38%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
7users have followed this narrative
4 days ago author updated this narrative
View Corbion Community

About the Company

FoundedEmployeesCEOWebsite
19192,407Olivier Rigaudwww.corbion.com

Corbion N.V. provides lactic acid and lactic acid derivatives, food preservation solutions, functional blends, and algae ingredients in the Netherlands, the United States, Asia, rest of North Americas, and the rest of Europe, the Middle East, and Africa. It operates through Functional Ingredients & Solutions and Health & Nutrition segments. The company offers acidification, color retention, decontamination, food safety and preservation, freshness and shelf life, health and nutrition, strengthening conditioning, and taste and texture food solutions; Purasorb R&D, a solution that offers a range of custom synthesis options; biochemical specialties solutions, such as solvency, antimicrobial, moisturization, and pharma; and algae ingredients solutions, including replacing fish oil and sustainable omega-3 sourcing.

Corbion N.V. Fundamentals Summary

How do Corbion's earnings and revenue compare to its market cap?
CRBN fundamental statistics
Market cap€1.04b
Earnings (TTM)€45.90m
Revenue (TTM)€1.29b

22.6x

P/E Ratio

0.8x

P/S Ratio

Is CRBN overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
CRBN income statement (TTM)
Revenue€1.29b
Cost of Revenue€968.50m
Gross Profit€319.60m
Other Expenses€273.70m
Earnings€45.90m

Last Reported Earnings

Dec 31, 2024

Next Earnings Date

Jul 31, 2025

Earnings per share (EPS)0.79
Gross Margin24.81%
Net Profit Margin3.56%
Debt/Equity Ratio58.3%

How did CRBN perform over the long term?

See historical performance and comparison

Dividends

3.6%

Current Dividend Yield

81%

Payout Ratio

Does CRBN pay a reliable dividends?

See CRBN dividend history and benchmarks
When do you need to buy CRBN by to receive an upcoming dividend?
Corbion dividend dates
Ex Dividend DateMay 16 2025
Dividend Pay DateMay 27 2025
Days until Ex dividend32 days
Days until Dividend pay date43 days

Does CRBN pay a reliable dividends?

See CRBN dividend history and benchmarks

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/04/13 12:50
End of Day Share Price 2025/04/11 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Corbion N.V. is covered by 24 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Robert Jan VosABN AMRO Bank N.V.
Setu ShardaBarclays
Sebastian BrayBerenberg